About Prostate Cancer
A Closer Look at Its Origins and Impact
Prostate cancer originates in the prostate gland, a small, walnut-sized organ located below the bladder and in front of the rectum. The prostate produces seminal fluid, which nourishes and transports sperm. Prostate cancer occurs when cells in the prostate grow uncontrollably, forming tumors. While many prostate cancers grow slowly and may not cause significant harm, others are aggressive and can spread rapidly to other parts of the body.
Symptoms
- Difficulty starting urination.
- Weak or interrupted urine flow.
- Frequent urination, especially at night.
- Difficulty emptying the bladder completely.
- Pain or burning during urination.
- Blood in urine or semen.
- Persistent pain in the back, hips, or pelvis.
- Erectile dysfunction.
It's important to note that early-stage prostate cancer often presents no symptoms, underscoring the importance of regular screenings.
Risk Factors
Age: The risk increases significantly after age 50, with about 60% of cases diagnosed in men over 65.
Family History: Having a father or brother with prostate cancer more than doubles a man's risk.
Race: African American men are 1.7 times more likely to be diagnosed and 2.1 times more likely to die from prostate cancer than white men.
Geography: Prostate cancer is more common in North America, northwestern Europe, Australia, and the Caribbean.
Genetic Factors: Inherited mutations in genes such as BRCA1, BRCA2, and Lynch syndrome can increase risk.
Global and Local Statistics
United States
Survival Rates
United States
Approximately 1 in 8 men will be diagnosed with prostate cancer during their lifetime. In 2025, an estimated 313,780 new cases and 35,770 deaths are expected.
Worldwide
Survival Rates
United States
Prostate cancer is the second most common cancer in men globally, with significant variations in incidence and mortality rates across different regions.
Survival Rates
Survival Rates
Survival Rates
The relative 5-year survival rate for prostate cancer diagnosed at localized stages is over 99%. However, for advanced or metastatic prostate cancer, this rate drops to 37%.